SCHEMBL29307757

SCHEMBL29307757

CCN(C)Cc1cccc(C2(c3ccccc3)c3ccccc3-c3ccccc32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.42
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ CHRNB2 P17787 1/20 0.39
▸ CHRNA4 P43681 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ MAOB P27338 3/20 0.37
▸ ACHE P22303 2/20 0.36
▸ OPRM1 P35372 3/20 0.36
▸ OPRL1 P41146 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ CARM1 Q86X55 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29307756 0.87 KMT2A (0.45) KMT2AESR1ESR2CHRNB2CHRNA4
SCHEMBL19735234 0.83 ALDH1A1 (0.43) KMT2AESR1ESR2KDM4ESMN1; SMN2
SCHEMBL19735230 0.83 ALDH1A1 (0.43) KMT2AESR1ESR2KDM4ESMN1; SMN2
SCHEMBL29307764 0.83 KMT2A (0.38) KMT2AESR1ESR2KDM4ESMN1; SMN2
SCHEMBL29307762 0.82 TSHR (0.56) KMT2AKDM4ESMN1; SMN2LMNAMAPT
SCHEMBL29307758 0.78 KMT2A (0.38) KMT2AESR1ESR2CHRNB2CHRNA4
SCHEMBL25707003 0.77 PDK2 (0.48) KMT2AESR1ESR2KDM4ESMN1; SMN2
SCHEMBL17903068 0.76 HTR1A (0.42) KMT2AESR1ESR2KDM4ESMN1; SMN2
SCHEMBL17854960 0.76 HTR1A (0.45) KMT2AESR1ESR2KDM4ESMN1; SMN2
SCHEMBL16995982 0.75 HTR7 (0.43) KMT2AESR1ESR2KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041847-B2 Compound for organic electric element, organic electric element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12041847-B2 Compound for organic electric element, organic electric element using the same, and electronic device thereof ORAI2, OR51E2, OR10J3 KMT2A 662/4885ESR1 4/4885ESR2 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback